Literature DB >> 2257242

Corticosteroids and the brain.

E R de Kloet1, J M Reul, W Sutanto.   

Abstract

Mineralocorticoid (MR) and glucocorticoid receptors (GR) are expressed in the central nervous system. Radioligand binding studies, autoradiography, immunocytochemistry and in situ hybridization have shown that MR and GR are found in abundance in neurons of the limbic system (hippocampus), a structure involved in mood, affect and subtle control of the hypothalamic-pituitary-adrenal (HPA) axis. In the hippocampus MR binds corticosterone (CORT) as well as aldosterone (ALDO) with high affinity. MR seems mainly occupied by CORT in the face of its 2-3 order higher circulating concentration. GR binds CORT with a 6-10-fold lower affinity. MR and GR gene expression, as well as the native receptor proteins, seem to be controlled in a coordinative manner. When GR is down-regulated by excess homologous steroid, MR appears to be increased. Down regulation of MR reduces GR as well. MR and GR display a differential ontogenetic pattern. Ontogeny, particularly that of GR, can be permanently influenced when animals are exposed during the first post-natal week of maternal deprivation, handling, CORT or ACTH1-24 injections. These MR and GR changes persist into senescence and have been proposed to result in altered CORT responsiveness, stress regulation, behavioural adaptation and brain aging.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257242     DOI: 10.1016/0960-0760(90)90489-8

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  28 in total

Review 1.  Neuronal cell cultures: a tool for investigations in developmental neurobiology.

Authors:  A Cestelli; G Savettieri; G Salemi; I Di Liegro
Journal:  Neurochem Res       Date:  1992-12       Impact factor: 3.996

2.  Transcription factor E2F-associated phosphoprotein (EAPP), RAM2/CDCA7L/JPO2 (R1), and simian virus 40 promoter factor 1 (Sp1) cooperatively regulate glucocorticoid activation of monoamine oxidase B.

Authors:  Kevin Chen; Xiao-Ming Ou; Jason Boyang Wu; Jean C Shih
Journal:  Mol Pharmacol       Date:  2010-10-27       Impact factor: 4.436

3.  The size of a melanin-based plumage ornament correlates with glucocorticoid receptor concentrations in the skin of that ornament.

Authors:  Christine R Lattin; L Michael Romero
Journal:  Biol Lett       Date:  2013-09-11       Impact factor: 3.703

Review 4.  Transcriptional regulation and multiple functions of MAO genes.

Authors:  Jean C Shih; Jason Boyang Wu; Kevin Chen
Journal:  J Neural Transm (Vienna)       Date:  2011-02-27       Impact factor: 3.575

5.  Hippocampal neurogenesis is not enhanced by lifelong reduction of glucocorticoid levels.

Authors:  Kristen L Brunson; Tallie Z Baram; Roland A Bender
Journal:  Hippocampus       Date:  2005       Impact factor: 3.899

6.  Effects of prenatal ethanol exposure on regulation of basal hypothalamic-pituitary-adrenal activity and hippocampal 5-HT1A receptor mRNA levels in female rats across the estrous cycle.

Authors:  J H Sliwowska; N Lan; F Yamashita; A G Halpert; V Viau; J Weinberg
Journal:  Psychoneuroendocrinology       Date:  2008-07-30       Impact factor: 4.905

7.  The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis.

Authors:  Shakevia Johnson; Shawna Tazik; Deyin Lu; Chandra Johnson; Moussa B H Youdim; Junming Wang; Grazyna Rajkowska; Xiao-Ming Ou
Journal:  Front Neurosci       Date:  2010-11-02       Impact factor: 4.677

8.  Comparative neuroprotective effects of rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis.

Authors:  Shawna Tazik; Shakevia Johnson; Deyin Lu; Chandra Johnson; Moussa B H Youdim; Craig A Stockmeier; Xiao-Ming Ou
Journal:  Neurotox Res       Date:  2009-02-28       Impact factor: 3.911

9.  Molecular basis for glucocorticoid induction of the Kruppel-like factor 9 gene in hippocampal neurons.

Authors:  Pia Bagamasbad; Tim Ziera; Steffen A Borden; Ronald M Bonett; Aaron M Rozeboom; Audrey Seasholtz; Robert J Denver
Journal:  Endocrinology       Date:  2012-09-07       Impact factor: 4.736

Review 10.  Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.

Authors:  Jamie Maguire; Jay A Salpekar
Journal:  Epilepsy Behav       Date:  2012-11-29       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.